Editorial: Stem cell funding is venture capital
By San Francisco Examiner,
San Francisco Examiner
| 08. 30. 2005
Last year's predictions of the benefits California would derive from approving Proposition 71 and funding stem cell research were overly optimistic, a recent study proclaimed.
The report, funded by universities and a biomedical trade association, concluded that while the state would benefit from new jobs, tax revenues and improvements to public health, requiring companies to pay for their use of research funding would stifle the participation of businesses.
In a sense, those using the report to oppose measures now under consideration in the state Legislature to codify how California will benefit from stem cell research are saying they want to consider billions of dollars in taxpayers' money not as a loan for investment purposes _ venture capital _ but instead as an outright gift.
Including interest, state taxpayers will likely end up paying $6 billion or more to repay the $3 billion in bonds.
The stem cell institute is scheduled to disburse its first grants soon, so let's be clear: Prop. 71's $3 billion in public money was not meant to be a gift. It was meant to be an...
Related Articles
By Smriti Mallapaty, Nature | 09.11.2024
Under his microscope, Jun Wu could see several tiny spheres, each less than 1 millimetre wide. They looked just like human embryos: a dark cluster of cells surrounded by a cavity, and then another ring of cells.
But Wu, a...
By Antonio Regalado, MIT Technology Review | 08.22.2024
In 2016, I attended a large meeting of journalists in Washington, DC. The keynote speaker was Jennifer Doudna, who just a few years before had co-invented CRISPR, a revolutionary method of changing genes that was sweeping across biology labs because...
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...